Celiac.com Sponsor:


Celiac.com Sponsor:

  • Join Our Community!

    Get help in our celiac / gluten-free forum.

  • Record is Archived

    This article is now archived and is closed to further replies.

    Jefferson Adams

    Rye Degraded with Germinating Barley Enzyme Shows Reduced Toxic Effects in Celiac Disease

    Jefferson Adams


    0
    Reviewed and edited by a celiac disease expert.   eNewsletter: Get our eNewsletter

    Caption: New research on rye.

    Celiac.com 06/30/2010 - Presently, the only proven treatment for celiac disease is a lifelong gluten-free diet. As part of a gluten-free diet, people with celiac disease are encouraged to avoid consuming foods containing rye, along with avoiding wheat and barley.

    However, there is surprisingly little evidence to document the adverse effects of rye in cases of celiac disease. To address this deficiency, a team of clinicians set out to determine conclusively whether rye should be excluded from the celiac diet.



    Celiac.com Sponsor:




    The team included S. M. Stenman, K. Lindfors, J. I. Venäläinen,  A. Hautala, P. T. Männistö,  J. A. Garcia-Horsman,  A. Kaukovirta-Norja, S. Auriola, T. Mauriala, M. Mäki, and K. Kaukinen

    They are affiliated variously with the Department of Pediatrics, and the Pediatric Research Center of the Medical School University of Tampere, the Department of Gastroenterology and Alimentary Tract Surgery at Tampere University Hospital, the Department of Pharmacology and Toxicology, the Department of Pharmaceutical Chemistry at the University of Kuopio, the Division of Pharmacology and Toxicology, the Division of Pharmaceutical Chemistry at the University of Helsinki, and Technical Research Centre of Finland.

    The goal of the team was to determine whether rye secalin triggers toxic reactions in vitro in intestinal epithelial cell models to the same degree as wheat gliadin.

    Moreover, they examined whether the harmful effects of secalin can be reduced by germinating cereal enzymes from oat, wheat and barley to hydrolyze secalin into short fragments as a pretreatment.

    The data showed that secalin did trigger toxic reactions in intestinal Caco-2 epithelial cells in a similar manner to gliadin. Secalin triggered epithelial cell layer permeability, tight junctional protein occludin and ZO-1 distortion, and actin reorganization.

    High-performance liquid chromatography and mass spectroscopy (HPLC-MS), showed that germinating barley enzymes best degraded the secalin and gliadin peptides. Further in vitro analysis showed that germinating barley enzyme pretreatment ameliorated all toxic secalin-triggered reactions.

    From these results, the team concludes that germinating enzymes from barley offer efficient degradation of rye secalin.

    In future, these enzymes might be utilized as a novel medical treatment for celiac disease or in food processing in order to develop high-quality celiac-safe food products.

    Such enzyme treatments might pave the way for either new treatments for celiac disease, or, new methods of processing rye for production of new, celiac-safe foods.


    SOURCE: Clinical & Experimental Immunology DOI:10.1111/j.1365-2249.2010.04119.x

    0

    User Feedback

    Recommended Comments

    Am I understanding this right? They are using enzymes from one toxic item to make another toxic item safe? This really doesn't make sense to me. Maybe I have this wrong...

    Share this comment


    Link to comment
    Share on other sites


    Guest
    This is now closed for further comments

  • About Me

    Jefferson Adams is Celiac.com's senior writer and Digital Content Director. He earned his B.A. and M.F.A. at Arizona State University, and has authored more than 2,500 articles on celiac disease. His coursework includes studies in science, scientific methodology, biology, anatomy, medicine, logic, and advanced research. He previously served as SF Health News Examiner for Examiner.com, and devised health and medical content for Sharecare.com. Jefferson has spoken about celiac disease to the media, including an appearance on the KQED radio show Forum, and is the editor of the book "Cereal Killers" by Scott Adams and Ron Hoggan, Ed.D.



  • A12 Celiac.com Sponsor:




  • Forum Discussions

    The studies are done by leading celiac research centers but they happen to be in Europe and not in the US because the product was developed in Delft and the closest University to Delft is Leiden. The University of Leiden is one of the oldest...
    This is exactly what AN-PEP does. It breaks down the gliadin molecule into small sequences of aminoacids (smaller than 8 aminoacids) and then it does not act like gluten anymore. 
    I am sorry that you are ill.  I am not sure that I understand your timeline.  You were diagnosed in November 2019.  At that time, you were also diagnosed or had earlier been diagnosed with Barrett’s and the hiatal hernia.  In November, your...